# Verrica Pharmaceuticals Inc.: Form 8-K, filed Sep 6, 2024

- Company: [Verrica Pharmaceuticals Inc.](/companies/vrca.md) (CIK 1660334)
- Form: 8-K
- Filed: 2024-09-06
- Accepted by EDGAR: Sep 6, 2024, 16:16 ET
- Period: 2024-08-30
- Accession: 0001193125-24-215180
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1660334/000119312524215180/d894672d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1660334/000119312524215180/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1660334/000119312524215180/d894672d8k.htm

Filed Sep 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-215180. Last ingested by Listed: Nov 14, 2026, 20:18 ET. No prices; not investment advice.
